4.5 Review

Trustworthy AI: Closing the gap between development and integration of AI systems in ophthalmic practice

Journal

PROGRESS IN RETINAL AND EYE RESEARCH
Volume 90, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.preteyeres.2021.101034

Keywords

Artificial intelligence; Deep learning; Machine learning; Trustworthiness; Integration; Ophthalmic care

Categories

Funding

  1. Deep Learning for Medical Image Analysis (DLMedIA) research program by The Dutch Research Council [P15-26]
  2. Innovative Medicines Initiative 2 Joint Undertaking [116076]
  3. European Union
  4. EFPIA
  5. Carl Zeiss Meditec AG
  6. RPB
  7. NEI/NIH [K23EY029246]
  8. NIA/NIH [U19AG066567]

Ask authors/readers for more resources

This study focuses on the importance of trustworthy AI in ophthalmology and identifies the key aspects and challenges that need to be considered in the design pipeline to generate trustworthy AI systems. Stakeholders' roles and responsibilities are defined, and a collaborative approach is emphasized for the potential benefits of AI to be realized in real-world ophthalmic settings.
An increasing number of artificial intelligence (AI) systems are being proposed in ophthalmology, motivated by the variety and amount of clinical and imaging data, as well as their potential benefits at the different stages of patient care. Despite achieving close or even superior performance to that of experts, there is a critical gap between development and integration of AI systems in ophthalmic practice. This work focuses on the importance of trustworthy AI to close that gap. We identify the main aspects or challenges that need to be considered along the AI design pipeline so as to generate systems that meet the requirements to be deemed trustworthy, including those concerning accuracy, resiliency, reliability, safety, and accountability. We elaborate on mechanisms and considerations to address those aspects or challenges, and define the roles and responsibilities of the different stakeholders involved in AI for ophthalmic care, i.e., AI developers, reading centers, healthcare providers, healthcare institutions, ophthalmological societies and working groups or committees, patients, regulatory bodies, and payers. Generating trustworthy AI is not a responsibility of a sole stakeholder. There is an impending necessity for a collaborative approach where the different stakeholders are represented along the AI design pipeline, from the definition of the intended use to post-market surveillance after regulatory approval. This work contributes to establish such multi-stakeholder interaction and the main action points to be taken so that the potential benefits of AI reach real-world ophthalmic settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available